Counter screening of hybridoma clones by indirect ELISA for performance using a provided compound (i.e., drug or endogenous protein). This charge applies to any or all phases of clonal selection.
產品描述
該COUNTER SCREENING (cost per compound, any/all phases) - MAB-079的詳細信息查看Rockland提供的產品說明書
產品形式
該COUNTER SCREENING (cost per compound, any/all phases) - MAB-079的詳細信息查看Rockland提供的產品說明書
保存建議
該COUNTER SCREENING (cost per compound, any/all phases) - MAB-079的詳細信息查看Rockland提供的產品說明書